44 research outputs found
RCC1L (WBSCR16) isoforms coordinate mitochondrial ribosome assembly through their interaction with GTPases.
Mitochondrial translation defects can be due to mutations affecting mitochondrial- or nuclear-encoded components. The number of known nuclear genes involved in mitochondrial translation has significantly increased in the past years. RCC1L (WBSCR16), a putative GDP/GTP exchange factor, has recently been described to interact with the mitochondrial large ribosomal subunit. In humans, three different RCC1L isoforms have been identified that originate from alternative splicing but share the same N-terminus, RCC1LV1, RCC1LV2 and RCC1LV3. All three isoforms were exclusively localized to mitochondria, interacted with its inner membrane and could associate with homopolymeric oligos to different extent. Mitochondrial immunoprecipitation experiments showed that RCC1LV1 and RCC1LV3 associated with the mitochondrial large and small ribosomal subunit, respectively, while no significant association was observed for RCC1LV2. Overexpression and silencing of RCC1LV1 or RCC1LV3 led to mitoribosome biogenesis defects that resulted in decreased translation. Indeed, significant changes in steady-state levels and distribution on isokinetic sucrose gradients were detected not only for mitoribosome proteins but also for GTPases, (GTPBP10, ERAL1 and C4orf14), and pseudouridylation proteins, (TRUB2, RPUSD3 and RPUSD4). All in all, our data suggest that RCC1L is essential for mitochondrial function and that the coordination of at least two isoforms is essential for proper ribosomal assembly
H+ transport is an integral function of the mitochondrial ADP/ATP carrier.
The mitochondrial ADP/ATP carrier (AAC) is a major transport protein of the inner mitochondrial membrane. It exchanges mitochondrial ATP for cytosolic ADP and controls cellular production of ATP. In addition, it has been proposed that AAC mediates mitochondrial uncoupling, but it has proven difficult to demonstrate this function or to elucidate its mechanisms. Here we record AAC currents directly from inner mitochondrial membranes from various mouse tissues and identify two distinct transport modes: ADP/ATP exchange and H+ transport. The AAC-mediated H+ current requires free fatty acids and resembles the H+ leak via the thermogenic uncoupling protein 1 found in brown fat. The ADP/ATP exchange via AAC negatively regulates the H+ leak, but does not completely inhibit it. This suggests that the H+ leak and mitochondrial uncoupling could be dynamically controlled by cellular ATP demand and the rate of ADP/ATP exchange. By mediating two distinct transport modes, ADP/ATP exchange and H+ leak, AAC connects coupled (ATP production) and uncoupled (thermogenesis) energy conversion in mitochondria
The Background of Mitochondrial DNA Haplogroup J Increases the Sensitivity of Leber's Hereditary Optic Neuropathy Cells to 2,5-Hexanedione Toxicity
Leber's hereditary optic neuropathy (LHON) is a maternally inherited blinding disease due to mitochondrial DNA (mtDNA) point mutations in complex I subunit genes, whose incomplete penetrance has been attributed to both genetic and environmental factors. Indeed, the mtDNA background defined as haplogroup J is known to increase the penetrance of the 11778/ND4 and 14484/ND6 mutations. Recently it was also documented that the professional exposure to n-hexane might act as an exogenous trigger for LHON. Therefore, we here investigate the effect of the n-hexane neurotoxic metabolite 2,5-hexanedione (2,5-HD) on cell viability and mitochondrial function of different cell models (cybrids and fibroblasts) carrying the LHON mutations on different mtDNA haplogroups. The viability of control and LHON cybrids and fibroblasts, whose mtDNAs were completely sequenced, was assessed using the MTT assay. Mitochondrial ATP synthesis rate driven by complex I substrates was determined with the luciferine/luciferase method. Incubation with 2,5-HD caused the maximal loss of viability in control and LHON cells. The toxic effect of this compound was similar in control cells irrespective of the mtDNA background. On the contrary, sensitivity to 2,5-HD induced cell death was greatly increased in LHON cells carrying the 11778/ND4 or the 14484/ND6 mutation on haplogroup J, whereas the 11778/ND4 mutation in association with haplogroups U and H significantly improved cell survival. The 11778/ND4 mutation on haplogroup U was also more resistant to inhibition of complex I dependent ATP synthesis by 2,5-HD. In conclusion, this study shows that mtDNA haplogroups modulate the response of LHON cells to 2,5-HD. In particular, haplogroup J makes cells more sensitive to its toxic effect. This is the first evidence that an mtDNA background plays a role by interacting with an environmental factor and that 2,5-HD may be a risk element for visual loss in LHON. This proof of principle has broad implications for other neurodegenerative disorders such as Parkinson's disease
MitoNeoD:a mitochondria-targeted superoxide probe
Mitochondrial superoxide (O2⋅−) underlies much oxidative damage and redox signaling. Fluorescent probes can detect O2⋅−, but are of limited applicability in vivo, while in cells their usefulness is constrained by side reactions and DNA intercalation. To overcome these limitations, we developed a dual-purpose mitochondrial O2⋅− probe, MitoNeoD, which can assess O2⋅− changes in vivo by mass spectrometry and in vitro by fluorescence. MitoNeoD comprises a O2⋅−-sensitive reduced phenanthridinium moiety modified to prevent DNA intercalation, as well as a carbon-deuterium bond to enhance its selectivity for O2⋅− over non-specific oxidation, and a triphenylphosphonium lipophilic cation moiety leading to the rapid accumulation within mitochondria. We demonstrated that MitoNeoD was a versatile and robust probe to assess changes in mitochondrial O2⋅− from isolated mitochondria to animal models, thus offering a way to examine the many roles of mitochondrial O2⋅−production in health and disease
Amino acid starvation has opposite effects on mitochondrial and cytosolic protein synthesis.
Amino acids are essential for cell growth and proliferation for they can serve as precursors of protein synthesis, be remodelled for nucleotide and fat biosynthesis, or be burnt as fuel. Mitochondria are energy producing organelles that additionally play a central role in amino acid homeostasis. One might expect mitochondrial metabolism to be geared towards the production and preservation of amino acids when cells are deprived of an exogenous supply. On the contrary, we find that human cells respond to amino acid starvation by upregulating the amino acid-consuming processes of respiration, protein synthesis, and amino acid catabolism in the mitochondria. The increased utilization of these nutrients in the organelle is not driven primarily by energy demand, as it occurs when glucose is plentiful. Instead it is proposed that the changes in the mitochondrial metabolism complement the repression of cytosolic protein synthesis to restrict cell growth and proliferation when amino acids are limiting. Therefore, stimulating mitochondrial function might offer a means of inhibiting nutrient-demanding anabolism that drives cellular proliferation
MPV17 Loss Causes Deoxynucleotide Insufficiency and Slow DNA Replication in Mitochondria
MPV17 is a mitochondrial inner membrane protein whose dysfunction causes mitochondrial DNA abnormalities and disease by an unknown mechanism. Perturbations of deoxynucleoside triphosphate (dNTP) pools are a recognized cause of mitochondrial genomic instability; therefore, we determined DNA copy number and dNTP levels in mitochondria of two models of MPV17 deficiency. In Mpv17 ablated mice, liver mitochondria showed substantial decreases in the levels of dGTP and dTTP and severe mitochondrial DNA depletion, whereas the dNTP pool was not significantly altered in kidney and brain mitochondria that had near normal levels of DNA. The shortage of mitochondrial dNTPs in Mpv17-/- liver slows the DNA replication in the organelle, as evidenced by the elevated level of replication intermediates. Quiescent fibroblasts of MPV17-mutant patients recapitulate key features of the primary affected tissue of the Mpv17-/- mice, displaying virtual absence of the protein, decreased dNTP levels and mitochondrial DNA depletion. Notably, the mitochondrial DNA loss in the patients’ quiescent fibroblasts was prevented and rescued by deoxynucleoside supplementation. Thus, our study establishes dNTP insufficiency in the mitochondria as the cause of mitochondrial DNA depletion in MPV17 deficiency, and identifies deoxynucleoside supplementation as a potential therapeutic strategy for MPV17-related disease. Moreover, changes in the expression of factors involved in mitochondrial deoxynucleotide homeostasis indicate a remodeling of nucleotide metabolism in MPV17 disease models, which suggests mitochondria lacking functional MPV17 have a restricted purine mitochondrial salvage pathway
OPA1 Isoforms in the Hierarchical Organization of Mitochondrial Functions
OPA1 is a GTPase that controls mitochondrial fusion, cristae integrity, and mtDNA maintenance. In humans, eight isoforms are expressed as combinations of long and short forms, but it is unclear whether OPA1 functions are associated with specific isoforms and/or domains. To address this, we expressed each of the eight isoforms or different constructs of isoform 1 in Opa1−/− MEFs. We observed that any isoform could restore cristae structure, mtDNA abundance, and energetic efficiency independently of mitochondrial network morphology. Long forms supported mitochondrial fusion; short forms were better able to restore energetic efficiency. The complete rescue of mitochondrial network morphology required a balance of long and short forms of at least two isoforms, as shown by combinatorial isoform silencing and co-expression experiments. Thus, multiple OPA1 isoforms are required for mitochondrial dynamics, while any single isoform can support all other functions. These findings will be useful in designing gene therapies for patients with OPA1 haploinsufficiency
MPV17L2 is required for ribosome assembly in mitochondria.
MPV17 is a mitochondrial protein of unknown function, and mutations in MPV17 are associated with mitochondrial deoxyribonucleic acid (DNA) maintenance disorders. Here we investigated its most similar relative, MPV17L2, which is also annotated as a mitochondrial protein. Mitochondrial fractionation analyses demonstrate MPV17L2 is an integral inner membrane protein, like MPV17. However, unlike MPV17, MPV17L2 is dependent on mitochondrial DNA, as it is absent from ρ(0) cells, and co-sediments on sucrose gradients with the large subunit of the mitochondrial ribosome and the monosome. Gene silencing of MPV17L2 results in marked decreases in the monosome and both subunits of the mitochondrial ribosome, leading to impaired protein synthesis in the mitochondria. Depletion of MPV17L2 also induces mitochondrial DNA aggregation. The DNA and ribosome phenotypes are linked, as in the absence of MPV17L2 proteins of the small subunit of the mitochondrial ribosome are trapped in the enlarged nucleoids, in contrast to a component of the large subunit. These findings suggest MPV17L2 contributes to the biogenesis of the mitochondrial ribosome, uniting the two subunits to create the translationally competent monosome, and provide evidence that assembly of the small subunit of the mitochondrial ribosome occurs at the nucleoid
Consensus Paper: Radiological Biomarkers of Cerebellar Diseases
Hereditary and sporadic cerebellar ataxias represent a vast and still growing group of diseases whose diagnosis and differentiation cannot only rely on clinical evaluation. Brain imaging including magnetic resonance (MR) and nuclear medicine techniques allows for characterization of structural and functional abnormalities underlying symptomatic ataxias. These methods thus constitute a potential source of radiological biomarkers, which could be used to identify these diseases and differentiate subgroups of them, and to assess their severity and their evolution. Such biomarkers mainly comprise qualitative and quantitative data obtained from MR including proton spectroscopy, diffusion imaging, tractography, voxel-based morphometry, functional imaging during task execution or in a resting state, and from SPETC and PET with several radiotracers. In the current article, we aim to illustrate briefly some applications of these neuroimaging tools to evaluation of cerebellar disorders such as inherited cerebellar ataxia, fetal developmental malformations, and immune-mediated cerebellar diseases and of neurodegenerative or early-developing diseases, such as dementia and autism in which cerebellar involvement is an emerging feature. Although these radiological biomarkers appear promising and helpful to better understand ataxia-related anatomical and physiological impairments, to date, very few of them have turned out to be specific for a given ataxia with atrophy of the cerebellar system being the main and the most usual alteration being observed. Consequently, much remains to be done to establish sensitivity, specificity, and reproducibility of available MR and nuclear medicine features as diagnostic, progression and surrogate biomarkers in clinical routine
Studies of OPA1 pathogenic mechanisms in Dominant Optic Atrophy and novel protein function in mitochondrial DNA stability
The mitochondrion is an essential cytoplasmic organelle that provides most of the energy
necessary for eukaryotic cell physiology. Mitochondrial structure and functions are
maintained by proteins of both mitochondrial and nuclear origin. These organelles are
organized in an extended network that dynamically fuses and divides. Mitochondrial
morphology results from the equilibrium between fusion and fission processes, controlled by
a family of “mitochondria-shaping” proteins. It is becoming clear that defects in
mitochondrial dynamics can impair mitochondrial respiration, morphology and motility,
leading to apoptotic cell death in vitro and more or less severe neurodegenerative disorders in
vivo in humans.
Mutations in OPA1, a nuclear encoded mitochondrial protein, cause autosomal Dominant
Optic Atrophy (DOA), a heterogeneous blinding disease characterized by retinal ganglion cell
degeneration leading to optic neuropathy (Delettre et al., 2000; Alexander et al., 2000). OPA1
is a mitochondrial dynamin-related guanosine triphosphatase (GTPase) protein involved in
mitochondrial network dynamics, cytochrome c storage and apoptosis. This protein is
anchored or associated on the inner mitochondrial membrane facing the intermembrane space.
Eight OPA1 isoforms resulting from alternative splicing combinations of exon 4, 4b and 5b
have been described (Delettre et al., 2001). These variants greatly vary among diverse organs
and the presence of specific isoforms has been associated with various mitochondrial
functions. The different spliced exons encode domains included in the amino-terminal region
and contribute to determine OPA1 functions (Olichon et al., 2006). It has been shown that
exon 4, that is conserved throughout evolution, confers functions to OPA1 involved in
maintenance of the mitochondrial membrane potential and in the fusion of the network.
Conversely, exon 4b and exon 5b, which are vertebrate specific, are involved in regulation of
cytochrome c release from mitochondria, and activation of apoptosis, a process restricted to
vertebrates (Olichon et al., 2007).
While Mgm1p has been identified thanks to its role in mtDNA maintenance, it is only recently
that OPA1 has been linked to mtDNA stability. Missense mutations in OPA1 cause
accumulation of multiple deletions in skeletal muscle. The syndrome associated to these
mutations (DOA-1 plus) is complex, consisting of a combination of dominant optic atrophy,
progressive external ophtalmoplegia, peripheral neuropathy, ataxia and deafness (Amati-
Bonneau et al., 2008; Hudson et al., 2008). OPA1 is the fifth gene associated with mtDNA
“breakage syndrome” together with ANT1, PolG1-2 and TYMP (Spinazzola et al., 2009).
In this thesis we show for the first time that specific OPA1 isoforms associated to exon 4b are
important for mtDNA stability, by anchoring the nucleoids to the inner mitochondrial membrane.
Our results clearly demonstrate that OPA1 isoforms including exon 4b are intimately
associated to the maintenance of the mitochondrial genome, as their silencing leads to
mtDNA depletion. The mechanism leading to mtDNA loss is associated with replication
inhibition in cells where exon 4b containing isoforms were down-regulated. Furthermore
silencing of exon 4b associated isoforms is responsible for alteration in mtDNA-nucleoids
distribution in the mitochondrial network.
In this study it was evidenced that OPA1 exon 4b isoform is cleaved to provide a 10kd peptide
embedded in the inner membrane by a second transmembrane domain, that seems to be
crucial for mitochondrial genome maintenance and does correspond to the second
transmembrane domain of the yeasts orthologue encoded by MGM1 or Msp1, which is also
mandatory for this process (Diot et al., 2009; Herlan et al., 2003). Furthermore in this thesis
we show that the NT-OPA1-exon 4b peptide co-immuno-precipitates with mtDNA and
specifically interacts with two major components of the mitochondrial nucleoids: the
polymerase gamma and Tfam. Thus, from these experiments the conclusion is that NT-OPA1-
exon 4b peptide contributes to the nucleoid anchoring in the inner mitochondrial membrane, a
process that is required for the initiation of mtDNA replication and for the distribution of
nucleoids along the network.
These data provide new crucial insights in understanding the mechanism involved in
maintenance of mtDNA integrity, because they clearly demonstrate that, besides genes
implicated in mtDNA replications (i.e. polymerase gamma, Tfam, twinkle and genes involved
in the nucleotide pool metabolism), OPA1 and mitochondrial membrane dynamics play also
an important role. Noticeably, the effect on mtDNA is different depending on the specific
OPA1 isoforms down-regulated, suggesting the involvement of two different combined
mechanisms.
Over two hundred OPA1 mutations, spread throughout the coding region of the gene, have
been described to date, including substitutions, deletions or insertions. Some mutations are
predicted to generate a truncated protein inducing haploinsufficiency, whereas the missense
nucleotide substitutions result in aminoacidic changes which affect conserved positions of the
OPA1 protein. So far, the functional consequences of OPA1 mutations in cells from DOA
patients are poorly understood. Phosphorus MR spectroscopy in patients with the
c.2708delTTAG deletion revealed a defect in oxidative phosphorylation in muscles (Lodi et
al., 2004). An energetic impairment has been also show in fibroblasts with the severe OPA1
R445H mutation (Amati-Bonneau et al., 2005). It has been previously reported by our group
that OPA1 mutations leading to haploinsufficiency are associated in fibroblasts to an oxidative
phosphorylation dysfunction, mainly involving the respiratory complex I (Zanna et al., 2008).
In this study we have evaluated the energetic efficiency of a panel of skin fibroblasts derived
from DOA patients, five fibroblast cell lines with OPA1 mutations causing haploinsufficiency
(DOA-H) and two cell lines bearing mis-sense aminoacidic substitutions (DOA-AA), and
compared with control fibroblasts. Although both types of DOA fibroblasts maintained a
similar ATP content when incubated in a glucose-free medium, i.e. when forced to utilize the
oxidative phosphorylation only to produce ATP, the mitochondrial ATP synthesis through
complex I, measured in digitonin-permeabilized cells, was significantly reduced in cells with
OPA1 haploinsufficiency only, whereas it was similar to controls in cells with the missense
substitutions.
Furthermore, evaluation of the mitochondrial membrane potential (DYm) in the two fibroblast
lines DOA-AA and in two DOA-H fibroblasts, namely those bearing the c.2819-2A>C
mutation and the c.2708delTTAG microdeletion, revealed an anomalous depolarizing
response to oligomycin in DOA-H cell lines only. This finding clearly supports the
hypothesis that these mutations cause a significant alteration in the respiratory chain function,
which can be unmasked only when the operation of the ATP synthase is prevented.
Noticeably, oligomycin-induced depolarization in these cells was almost completely
prevented by preincubation with cyclosporin A, a well known inhibitor of the permeability
transition pore (PTP). This results is very important because it suggests for the first time that
the voltage threshold for PTP opening is altered in DOA-H fibroblasts. Although this issue
has not yet been addressed in the present study, several are the mechanisms that have been
proposed to lead to PTP deregulation, including in particular increased reactive oxygen
species production and alteration of Ca2+ homeostasis, whose role in DOA fibroblasts PTP
opening is currently under investigation. Identification of the mechanisms leading to altered
threshold for PTP regulation will help our understanding of the pathophysiology of DOA, but
also provide a strategy for therapeutic intervention